Parkman Healthcare Partners’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Parkman Healthcare Partners’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-932,141	Closed	-$3.1M	–	84
2019 Q4	$3.1M	Buy	+932,141	New	+$2.96M	0.9%	39

Parkman Healthcare Partners's FOMX Position: Q1 2020 in Review

Parkman Healthcare Partners sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 932,141 shares — an estimated $3.1M sold.

Parkman Healthcare Partners first reported a position in FOMX in Q4 2019 and held it in 1 quarter. The position peaked at $3.1M in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Parkman Healthcare Partners reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Parkman Healthcare Partners sold 932,141 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $3.1M.
Parkman Healthcare Partners first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2019 and held it in 1 quarter.
Parkman Healthcare Partners's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $3.1M in Q4 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Parkman Healthcare Partners's 13F filing for Q1 2020, filed 15 May 2020.